NCT00126945View on ClinicalTrials.gov

Evaluate 4 Different Formulations of Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

October 31, 2005

Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL

Meningococcal Vaccine

Trial Locations (1)

8200

GSK Investigational Site, Aarhus N

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY